DOCSLIB.ORG

Perioperative Management of Oral Glucose-Lowering Drugs in The

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Perioperative Management of Oral Glucose-Lowering Drugs in The CLINICAL FOCUS REVIEW Jerrold H. Levy, M.D., F.A.H.A., F.C.C.M., Editor Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes Jean-Charles Preiser, M.D., Ph.D., Bruna Provenzano, M.D., Wasineeart Mongkolpun, M.D., Katarina Halenarova, M.D., Miriam Cnop, M.D., Ph.D. iabetes mellitus is a group of metabolic disorders, urgent cholecystectomy in insulin-requiring diabetic patients characterized by hyperglycemia, resulting from rela- than in orally treated diabetic patients, possibly pointing to D Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/133/2/430/514400/20200800.0-00029.pdf by guest on 02 October 2021 tive insulin deficiency, often on a background of insulin worse outcomes in people with more advanced diabetes resistance (type 2 diabetes), or (near) absolute insulin defi- and/or more severe comorbidities. ciency related to autoimmune pathophysiology (type 1 dia- Surgical stress induces insulin resistance and increased betes). The most common form is type 2 diabetes, and its endogenous glucose production, resulting in stress hyper- global prevalence is rising as a result of changes in lifestyle glycemia characterized by blood glucose level greater than and lengthening of life expectancy.1,2 An estimated 463 mil- 180 mg/dl (10 mM).15–18 When this persists, elevated glucose lion people aged 20 to 79 yr have diabetes,3 which cor- levels become deleterious, promoting immune dysfunction responds to 9.3% of the adult population and represents and susceptibility to infections, endothelial dysfunction and a four-fold increase in diabetes prevalence since 1980.4 thrombosis that can culminate in stroke and acute myo- Patients with type 2 diabetes often have comorbidities such cardial infarction, and oxidative stress caused by enhanced as arterial hypertension, obesity, ischemic heart disease, renal reactive oxygen species production.19 failure, and atherosclerosis. Ischemic heart disease in partic- In the intensive care setting, stress hyperglycemia, spon- ular may affect younger patients compared to nondiabetic taneous or drug-related hypoglycemia (glucose less than populations and may have silent ischemia. Hence, assessing 70 mg/dl [3.89 mM]) and high glycemic variability (coef- the preoperative risk of diabetic patients is challenging, and ficient of variation greater than 20%) constitute the three can be underestimated. As shown outside the perioperative features of dysglycemia syndrome. All are associated with setting, these patients have equivalent or higher risk for worse outcomes in acutely injured patients.20–22 Badawi et cardiovascular events and mortality as patients with typical al.22 analyzed a large cohort of critically ill patients from angina.5,6 However, current guidelines recommend against 344 American intensive care units to evaluate the associa- systematic stress testing in individuals without symptoms.7,8 tion between intensive care unit–acquired dysglycemia and The number of type 2 diabetes patients undergoing sur- in-hospital mortality. The results showed that hypoglycemia gical procedures is rising worldwide. An American review as well as hyperglycemia and glucose variability are delete- from 2004 estimated that 15 to 20% of surgical patients are rious to critically ill patients. The longer the duration of this diabetic.4 Twenty-five percent of type 2 diabetes patients will variability, the greater is the impact on in-hospital mortality. require a surgical procedure during their lifetime9 related to The adjusted relative risk (95% CI) of mortality for hyper- chronic complications that affect the cardiovascular, ophthal- glycemia (glucose, 180 to 240 mg/dl [10 to 13.3 mM]) was mologic, renal or orthopedic systems. The risk of postoper- 1.63 (1.47 to 1.81). The relative risk for glycemic variability ative complications (i.e., gastroparesis, cardiovascular events, was 1.61 (1.47 to 1.78), and for hypoglycemia (glucose, 40 and postoperative infection) in type 2 diabetes patients is to 60 mg/dl [2.2 to 3.3 mM]) it was 1.53 (1.37 to 1.70). higher than in nondiabetic patients, as reported by large-scale The optimal glycemic control in diabetic patients should studies.4,5,9–12 In order to adjust for potential confounders, the also consider the prior level of glucose control, indicated by adverse outcomes occurring after major surgery have been the level of glycated hemoglobin. The “stress hyperglycemia compared with a propensity-matched cohort of non-diabetic ratio” and the “glycemic ratio” were introduced to calcu- patients in a cohort of more than 33,000 patients in Taiwan.13 late the difference between actual and average glycemia.23,24 In this study, Lin et al. found a higher risk of postoperative The estimated average glucose value derived from glycated sepsis (odds ratio, 1.33; 95% CI, 1.01 to 1.74) and in-hospital hemoglobin could be the optimal target range, as suggested mortality (odds ratio, 1.51; 95% CI, 1.07 to 2.13) when com- by reports of lower mortality or reduced need for inten- pared to nondiabetic patients. Karamanos et al.14 demonstrated sive care when glucose was closer to the average value.23,24 higher mortality, cardiovascular and renal complications after In surgical intensive care patients, and in particular for This article has been selected for the Anesthesiology CME Program. Learning objectives and disclosure and ordering information can be found in the CME section at the front of this issue. This article is featured in “This Month in Anesthesiology,” page 1A. Submitted for publication August 30, 2019. Accepted for publication February 11, 2020. Published online first on March 12, 2020. From the Departments of Intensive Care (J.-C.P., B.P., W.M., K.H.) and Anesthesiology (K.H.), Erasmus Hospital, the Division of Endocrinology (M.C.), and the Center for Diabetes Research (M.C.), Free University of Brussels, Brussels, Belgium. Copyright © 2020, the American Society of Anesthesiologists, Inc. All Rights Reserved. Anesthesiology 2020; 133:430–8. DOI: 10.1097/ALN.0000000000003237 430 AUGUST 2020 ANESTHESIOLOGY, V 133 • NO 2 Copyright © 2020, the American Society of Anesthesiologists, Inc. Unauthorized reproduction of this article is prohibited. Perioperative Management of Glucose-lowering Drugs scheduled surgeries, perioperative care should focus on the long-acting insulin secretagogues. Meglitinides constitute prevention of dysglycemia in order to improve outcomes. another class of insulin secretagogues that are taken with The proper management of oral glucose-lowering treat- meals and are more rapid and short-acting. The currently ment in type 2 diabetic patients is therefore crucial. available second generation sulfonylurea include gliclazide, glimepiride and glyburide or glibenclamide. The megli- New Oral Glucose-lowering Drugs tinides include repaglinide and nateglinide. These drugs bind the sulfonylurea receptor, and thereby close potassium Type 2 diabetes treatment has undergone major changes adenosine triphosphate channels in pancreatic β cells, result- with the development of new drug classes, such as sodi- ing in membrane depolarization, calcium influx and insu- um-glucose cotransporter-2 inhibitors, and demonstra- lin release. The American Diabetes Association (Arlington, tion of their safety and efficacy in large-scale clinical trials. Virginia) recommends sulfonylurea or meglitinides as In recent trials primary outcomes were cardiovascular, Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/133/2/430/514400/20200800.0-00029.pdf by guest on 02 October 2021 add-on oral treatment when metformin does not suffice, whereas the primary outcome of previous trials was gly- in the absence of atherosclerotic cardiovascular disease or cemic control.25 This change in paradigm was mandated by chronic kidney disease. the United States Food and Drug Administration, which, Clinical studies assessed the efficacy of sulfonylurea since 2008, has required data on cardiovascular safety for on glycemic control.28 A meta-analysis of 31 trials with a new glucose-lowering drugs, after the finding increased median 16-week duration of showed that sulfonylurea in rates of myocardial infarction and cardiovascular mortality mono- or combination therapy with another drug low- in patients randomized to rosiglitazone in a meta-analysis of 42 studies.26 These changes show the complexity of oral ered glycated hemoglobin by 1.5% (17 mmol/mol; 95% glucose-lowering drug use in type 2 diabetic patients. CI, 1.3 to 1.8) and 1.6% (18 mmol/mol; 95% CI, 1.0 to In practice, the current recommendations for the man- 2.2), respectively. Sulfonylurea are cheaper than other oral agement of type 2 diabetes are simple for the initiation of glucose-lowering drugs recommended as second step. pharmacologic treatment: metformin is the first agent to be Meglitinides were mostly tested as an adjunctive therapy to started, unless contraindicated (such as a reduction in glo- metformin, and combination therapy safely improved gly- 29 merular filtration rate less than 30 ml/min). Therapeutic effi- cemic control (meta-analysis of 22 trials). cacy is monitored by the level of glycated hemoglobin. Once As the effects of sulfonylurea are independent of metformin is no longer sufficient despite adequate dosing, a circulating glucose levels, there is an increased risk of second oral medication (e.g., sulfonylurea, thiazolidinedione, hypoglycemic events. The rate of hypoglycemia was a sodium-glucose cotransporter-2 inhibitor, a dipeptidyl increased by 2.4-fold in patients treated with sulfony- 28 peptidase-4 inhibitor) or a glucagon-like peptide 1 analog lurea as compared with other glucose-lowering agents. should be selected, taking into consideration the individual This risk can further increase in the hospital, as a result patient’s risk of atherosclerotic cardiovascular disease, heart of differences between hospital diets and usual dietary failure, or chronic kidney disease.27 If combination ther- habits. Hypoglycemia appears to be less of a risk for 30 apy does not suffice, combination therapy with a third oral meglitinides but still is relatively high. Besides the glucose-lowering drug or insulin must be considered.
Load more

Recommended publications
  • Higher Mortality Rate in Moderate-To-Severe Thoracoabdominal Injury Patients with Admission Hyperglycemia Than Nondiabetic Normoglycemic Patients
    International Journal of Environmental Research and Public Health Article Higher Mortality Rate in Moderate-to-Severe Thoracoabdominal Injury Patients with Admission Hyperglycemia Than Nondiabetic Normoglycemic Patients 1, 2, 1 1 1 Wei-Ti Su y, Shao-Chun Wu y , Sheng-En Chou , Chun-Ying Huang , Shiun-Yuan Hsu , 1, , 3, , Hang-Tsung Liu z * and Ching-Hua Hsieh z * 1 Department of Trauma Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University and College of Medicine, Kaohsiung 83301, Taiwan; [email protected] (W.-T.S.); [email protected] (S.-E.C.); [email protected] (C.-Y.H.); [email protected] (S.-Y.H.) 2 Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University and College of Medicine, Kaohsiung 83301, Taiwan; [email protected] 3 Department of Plastic Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University and College of Medicine, Kaohsiung 83301, Taiwan * Correspondence: [email protected] (H.-T.L.); [email protected] (C.-H.H.) These authors contribute equally to this paper as the first author. y These authors contribute equally to this paper as the corresponding author. z Received: 21 August 2019; Accepted: 23 September 2019; Published: 25 September 2019 Abstract: Background: Hyperglycemia at admission is associated with an increase in worse outcomes in trauma patients. However, admission hyperglycemia is not only due to diabetic hyperglycemia (DH), but also stress-induced hyperglycemia (SIH). This study was designed to evaluate the mortality rates between adult moderate-to-severe thoracoabdominal injury patients with admission hyperglycemia as DH or SIH and in patients with nondiabetic normoglycemia (NDN) at a level 1 trauma center.
    [Show full text]
  • Prevention of Stress Hyperglycemia with the Use of DPP-4 Inhibitors in Non-Diabetic Patients Undergoing Non-Cardiac Surgery, a Pilot Study (SITA-SURGERY PILOT TRIAL)
    Title: Prevention of stress hyperglycemia with the use of DPP-4 inhibitors in non-diabetic patients undergoing non-cardiac surgery, a Pilot Study (SITA-SURGERY PILOT TRIAL). Principal Investigator: Maya Fayfman, M.D. Instructor of Medicine Department of Medicine/Endocrinology Emory University School of Medicine Co-Investigators: Department of Medicine: Guillermo Umpierrez, MD, Priyathama Vellanki, MD, David Reyes, MD, Georgia Davis, MD, Saumeth Cardona, David Chachkhiani, Clementina Ramos Garrido, David Alfa, and Maria Urrutia Department of Surgery: Sheryl Gabram-Mendola and MD, Mara Schenker, MD Department of Anesthesiology Elizabeth Duggan, MD, Jay Sanford MD and Joanna Schindler MD School of Public Health Limin Peng, PhD Investigator-Sponsor: Guillermo Umpierrez, MD. Division of Endocrinology, Department of Medicine ABSTRACT Approximately 51.4 million surgical procedures are performed in the United States each year.1 Over 40% of patients both with and without diabetes (DM) develop stress hyperglycemia (defined as a BG >140 mg/dl) after general surgery.2,3 Compared to patients without DM, those with DM have higher rates of complications that include wound infections,4,5 acute renal failure,6 longer hospital stay,7,8 and perioperative mortality.8,9 However, non-DM patients with stress hyperglycemia have poor surgical outcome after cardiac surgery with even higher rates of complications and mortality compared to those with DM.10,11 Few observational studies looking at non- cardiac patients have found that stress hyperglycemia is associated
    [Show full text]
  • The Association of Admission Blood Glucose Level with the Clinical Picture and Prognosis in Cardiogenic Shock – Results from the Cardshock Study☆
    International Journal of Cardiology 226 (2017) 48–52 Contents lists available at ScienceDirect International Journal of Cardiology journal homepage: www.elsevier.com/locate/ijcard The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock – Results from the CardShock Study☆ Anu Kataja a,⁎,1, Tuukka Tarvasmäki a,1,JohanLassusb,1, Jose Cardoso c,1, Alexandre Mebazaa d,1,LarsKøbere,1, Alessandro Sionis f,1, Jindrich Spinar g,1, Valentina Carubelli h,1, Marek Banaszewski i,1, Rossella Marino j,1, John Parissis k,1, Markku S. Nieminen b,1, Veli-Pekka Harjola a,1 a Emergency Medicine, University of Helsinki, Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland b Cardiology, University of Helsinki, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland c CINTESIS - Center for Health Technology and Services Research, Department of Cardiology, Faculty of Medicine, University of Porto, São João Medical Center, Porto, Portugal d INSERM U942, Hopital Lariboisiere, APHP and University Paris Diderot, Paris, France e Rigshospitalet, Copenhagen University Hospital, Division of Heart Failure, Pulmonary Hypertension and Heart Transplantation, Copenhagen, Denmark f Intensive Cardiac Care Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute IIB-Sant Pau, Universitat de Barcelona, Barcelona, Spain g Internal Cardiology Department, University Hospital Brno and Masaryk University, Brno, Czech republic h Division
    [Show full text]
  • Post-Operative Stress Hyperglycemia Is a Predictor of Mortality in Liver
    Giráldez et al. Diabetol Metab Syndr (2018) 10:35 https://doi.org/10.1186/s13098-018-0334-5 Diabetology & Metabolic Syndrome RESEARCH Open Access Post‑operative stress hyperglycemia is a predictor of mortality in liver transplantation Elena Giráldez1* , Evaristo Varo2, Ipek Guler3, Carmen Cadarso‑Suarez3, Santiago Tomé2, Patricia Barral1, Antonio Garrote1 and Francisco Gude4 Abstract Background: A signifcant association is known between increased glycaemic variability and mortality in critical patients. To ascertain whether glycaemic profles during the frst week after liver transplantation might be associated with long-term mortality in these patients, by analysing whether diabetic status modifed this relationship. Method: Observational long-term survival study includes 642 subjects undergoing liver transplantation from July 1994 to July 2011. Glucose profles, units of insulin and all variables with infuence on mortality are analysed using joint modelling techniques. Results: Patients registered a survival rate of 85% at 1 year and 65% at 10 years, without diferences in mortal‑ ity between patients with and without diabetes. In glucose profles, however, diferences were observed between patients with and without diabetes: patients with diabetes registered lower baseline glucose values, which gradually rose until reaching a peak on days 2–3 and then subsequently declined, diabetic subjects started from higher values which gradually decreased across the frst week. Patients with diabetes showed an association between mortality and age, Model for End-Stage Liver Disease score (MELD) score and hepatitis C virus; among non-diabetic patients, mortal‑ ity was associated with age, body mass index, malignant aetiology, red blood cell requirements and parenteral nutri‑ tion. Glucose profles were observed to be statistically associated with mortality among patients without diabetes (P 0.022) but not among patients who presented with diabetes prior to transplantation (P 0.689).
    [Show full text]
  • Overnight Caloric Restriction Prior to Cardiac Arrest and Resuscitation Leads to Improved Survival and Neurological Outcome in a Rodent Model
    bioRxiv preprint doi: https://doi.org/10.1101/786871; this version posted September 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Overnight caloric restriction prior to cardiac arrest and resuscitation leads to improved survival and neurological outcome in a rodent model Matine Azadian1, Guilian Tian1, Afsheen Bazrafkan1, Niki Maki1, Masih Rafi1, Monica Desai1, Ieeshiah Otarola1, Shuhab Zaher1, Ashar Khan1, Yusuf Suri1, Minwei Wang1, Oswald Steward2, Yama Akbari1, 3, 4 1Department of Neurology, School of Medicine, University of California, Irvine, CA, USA 2Reeve-Irvine Research Center, Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, CA, USA 3Beckman Laser Institute, University of California, Irvine, CA, USA 4Department of Neurological Surgery, School of Medicine, University of California, Irvine, CA, USA Abstract While interest toward caloric restriction (CR) in various models of brain injury has increased in recent decades, studies have predominantly focused on the benefits of chronic or intermittent CR. The effects of ultra-short, including overnight, CR on acute ischemic brain injury, however, are not well studied. Here, we show that overnight caloric restriction (75% over 14 h) prior to asphyxial cardiac arrest and resuscitation (CA) improves survival and neurological recovery, including complete prevention of neurodegeneration in multiple regions of the brain. We also show that overnight CR normalizes stress-induced hyperglycemia, while significantly decreasing insulin and glucagon production and increasing corticosterone and ketone body production.
    [Show full text]
  • Thromboembolism Risk Among Patients with Diabetes/Stress
    medRxiv preprint doi: https://doi.org/10.1101/2021.04.17.21255540; this version posted May 17, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. 1 Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID- 2 19 3 Stefania L Calvisi1§; Giuseppe A Ramirez2,3§; Marina Scavini4; Valentina Da Prat1; Giuseppe 4 Di Lucca1; Andrea Laurenzi4,5; Gabriele Gallina1,3; Ludovica Cavallo1,3; Giorgia Borio1,3; 5 Federica Farolfi1,3; Maria Pascali1,3; Jacopo Castellani1,3; Vito Lampasona4; Armando 6 D’Angelo3,6; Giovanni Landoni3,7; Fabio Ciceri3,7; Patrizia Rovere Querini3,5; Moreno 7 Tresoldi1*; Lorenzo Piemonti3,4* 8 9 1 Unit of General Medicine and Advanced Care, IRCCS Ospedale San Raffaele, Milan, Italy 10 2 Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele 11 Scientific Institute, Milan, Italy 12 3 Università Vita-Salute San Raffaele, Milan, Italy 13 4 Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. 14 5 Unit of Internal Medicine and Endocrinology, IRCCS Ospedale San Raffaele, Milan, Italy 15 6 Coagulation service and Thrombosis Research Unit, IRCCS Ospedale San Raffaele, Milan, 16 Italy 17 7 Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, 18 Milan, Italy 19 8 Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, 20 Italy.
    [Show full text]
  • Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: an Endocrine Society Clinical Practice Guideline
    SPECIAL FEATURE Clinical Practice Guideline Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline Guillermo E. Umpierrez, Richard Hellman, Mary T. Korytkowski, Mikhail Kosiborod, Gregory A. Maynard, Victor M. Montori, Jane J. Seley, and Greet Van den Berghe Emory University School of Medicine (G.E.U.), Atlanta, Georgia 30322; Heart of America Diabetes Research Foundation and University of Missouri-Kansas City School of Medicine (R.H.), North Kansas City, Missouri 64112; University of Pittsburgh School of Medicine (M.T.K.), Pittsburgh, Pennsylvania 15213; Saint Luke’s Mid-America Heart Institute and University of Missouri-Kansas City (M.K.), Kansas City, Missouri 64111; University of California San Diego Medical Center (G.A.M.), San Diego, California 92037; Mayo Clinic Rochester (V.M.M.), Rochester, Minnesota 55905; New York-Presbyterian Hospital/ Weill Cornell Medical Center (J.J.S.), New York, New York 10065; and Catholic University of Leuven (G.V.d.B.), 3000 Leuven, Belgium Objective: The aim was to formulate practice guidelines on the management of hyperglycemia in hospitalized patients in the non-critical care setting. Participants: The Task Force was composed of a chair, selected by the Clinical Guidelines Subcom- mittee of The Endocrine Society, six additional experts, and a methodologist. Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of rec- ommendations and the quality of evidence. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Endocrine Society members, American Diabetes Association, American Heart Association, American Association of Diabetes Educators, European Society of Endocri- nology, and the Society of Hospital Medicine reviewed and commented on preliminary drafts of this guideline.
    [Show full text]
  • Hyperglycemia in the Intensive Care Unit Yoğun Bakım Ünitesinde Hiperglisemi
    Journal of the Turkish Society of Intensive Care (2014)12: 67-71 DOI: 10.4274/tybdd.03521 REVIEW / DERLEME Rainer Lenhardt, Ozan Akca Hyperglycemia in the Intensive Care Unit Yoğun Bakım Ünitesinde Hiperglisemi SUMMARY Hyperglycemia is frequently The goal of this review was to give a Received/Geliş Tarihi : 23.12.2014 Accepted/Kabul Tarihi : 13.01.2015 encountered in the intensive care unit. In brief overview about pathophysiology of Journal of the Turkish Society of Intensive Care, published this disease, after severe injury and during hyperglycemia and to summarize current by Galenos Publishing diabetes mellitus homeostasis is impaired; guidelines for glycemic control in critically ill Türk Yo€un Bak›m Derneği Dergisi, Galenos Yay›nevi taraf›ndan bas›lm›flt›r. hyperglycemia, hypoglycemia and glycemic patients. ISSN: 2146-6416 variability may ensue. These three states Key Words: Hyperglycemia, blood glucose have been shown to independently increase control, intensive care unit mortality and morbidity. Patients with ÖZET Yoğun bakım ünitesinde diabetics admitted to the intensive care unit hiperglisemiye sıklıkla rastlanmaktadır. tolerate higher blood glucose values without Rainer Lenhardt, Ozan Akca, Hastalık durumlarında ağır hasar sonrasında increase of mortality. Stress hyperglycemia University of Louisville, Department of ve diyabetes mellitus sürecinde homeostaz Anesthesiology and Perioperative Medicine, may occur in patients with or without Louisville, USA bozulur, hiperglisemi, hipoglisemi ve diabetes and has a strong association with glisemik değişkenlik meydana gelebilir. Bu Rainer Lenhardt M.D. (✉), increased mortality in the intensive care unit üç durumun bağımsız olarak mortalite ve University of Louisville, Department of patients. Insulin is the drug of choice to treat morbiditeyi artırdığı gösterilmiştir.
    [Show full text]
  • Almost Every One of Us Knows Someone Who Has Diabetes
    DIABETES & Hypoglycemia 8.0 Contact Hours California Board of Registered Nursing CEP#15122 Compiled by Terry Rudd RN, MSN Key Medical Resources, Inc. P.O. Box 2033 Rancho Cucamonga, CA 91729 Training Center: 9774 Crescent Center Drive, Suite 505, Rancho Cucamonga, CA 91730 909 980-0126 FAX: 909 980-0643 Email: [email protected] See www.cprclassroom.com for other Key Medical Resources classes, services, and programs. 1 DIABETES AND HYPOGLYCEMIA Self Study 8.0 C0NTACT HOURS CEP #15122 Please note that C.N.A.s cannot receive continuing education hours for this home study. 1. Please print or type all information. 2. Arrange payment of $3 per contact hour to Key Medical Resources, Inc. Call for credit card payment. 3. No charge for contract personnel or Key Medical Passport holders. 4. Please complete answers and return SIGNED answer sheet with evaluation form via FAX: 909 980-0643 or Email: [email protected]. Put "Self Study" on subject line. Name: ___________________________________ Date Completed: ______________ Email:_____________________________ Cell Phone: ( ) ______________ Address: _________________________________ City: _________________ Zip: _______ License # & Type: (i.e. RN 555555) _________________Place of Employment: ____________ Place your answer of this sheet or the scan-type form provided. 1. _____ 9. _____ 17. _____ 25. _____ 33. _____ 2. _____ 10. _____ 18. _____ 26. _____ 34. _____ 3. _____ 11. _____ 19. _____ 27. _____ 35. _____ 4. _____ 12. _____ 20. _____ 28. _____ 36. _____ 5. _____ 13. _____ 21. _____ 29. _____ 37. _____ 6. _____ 14. _____ 22. _____ 30. _____ 38. _____ 7. _____ 15.
    [Show full text]
  • Study of Stress Hyperglycemia As a Prognostic Factor in Acute Myocardial Infarction Patients Dissertation Submitted for M
    STUDY OF STRESS HYPERGLYCEMIA AS A PROGNOSTIC FACTOR IN ACUTE MYOCARDIAL INFARCTION PATIENTS DISSERTATION SUBMITTED FOR M.D.DEGREE EXAMINATION BRANCH I GENERAL MEDICINE MARCH 2007 THANJAVUR MEDICAL COLLEGE THANJAVUR THE TAMILNADU DR.M.G.R.MEDICAL UNIVERSITY CHENNAI BONAFIDE CERTIFICATE This is to certify that this dissertation entitled ‘‘STUDY OF STRESS HYPERGLYCEMIA AS A PROGNOSTIC FACTOR IN ACUTE MYOCARDIAL INFARCTION PATIENTS’’ submitted by Dr. J.Vijaya kumar to the faculty of GeneralMedicine ,The Tamil Nadu Dr.M.G.R.Medical University ,Chennai in partial fulfillment of the requirement for the award of M.D.Degree Branch 1[General Medicine] is a bonafide research work carried out by him under my direct supervision and guidance. Dr.K.Gandhi.M.D. PROFESSOR AND HEAD DEPARTMENT OF MEDICINE THANJAVUR MEDICAL COLLEGE HOSPITAL THANJAVUR. ACKNOWLEDGEMENT It gives me great pleasure to acknowledge all those who guided,encouraged and supported me in the successful completion of my dissertation. I express my gratitude and sincere thanks to our beloved chief Professor.Dr.K.GANDHI M.D.,Professor&Head of the Department of Medicine,for his infallible guidance and unfailing support. My gratitude to the Dean(i/c),Dr.BALAKRISHNAN M.D.for allowing me to utilize the facilities available in Thanjavur Medical College Hospital,for doing my dissertation. I wish to extend my gratitude to all my respected teachers Dr.JEEVA M.D.,Dr.MUTHUKUMARAN M.D, Dr.DHANDAPANI M.D.and Dr.SUKUMARAN M.D.,for their graceful guidance in choosing the topic and completing the study. My sincere thanks to my unit Assistsnt Professors Dr.P.KRISHNAMOORTHY M.D.and Dr.A.RAJENDRAN M.D.for their guidance and help throughout the study.
    [Show full text]
  • Stress Response to Total Abdominal Hysterectomy Under General
    a & hesi C st lin e ic n a l A f R Sardar et al., J Anesthe Clinic Res 2013, 4:6 o e l s e a Journal of Anesthesia & Clinical DOI: 10.4172/2155-6148.1000329 a n r r c u h o J ISSN: 2155-6148 Research Research Article Open Access Stress Response to Total Abdominal Hysterectomy under General Anesthesia in Type 2 Diabetic Subjects Kawsar Sardar1*, Hafizur Rahman M2, Abdur Rashid M2, Omar Faruque M2, Liaquat Ali2, Shahera Khatun UH3 and Mesbahuddin Iqbal K4 1Dept Anesthesiology, BIRDEM Hospital and Ibrahim Medical College, Dhaka, Bangladesh 2Dept of Biochemistry and Cell Biology, BIRDEM, Dhaka, Bangladesh 3Dept of Anesthesiology and Intensive Care Medicine, Dhaka Medical College, Dhaka, Bangladesh 4Chief Consultant, Dept Anesthesiology, Apollo Hospital, Dhaka, Bangladesh Abstract Aims: This study was designed to investigate the hemodynamic alteration and changes of glycemic, cortisol and electrolytes status in total abdominal hysterectomy of type 2 diabetic subjects under general anesthesia. Subjects and method: Fourty subjects under general anesthesia for total abdominal hysterectomy were recruited and thrice blood samples were collected from each subject, before anesthesia (PT0), 10 minutes after incision (PT1) and 10 minutes after extubation (PT2). Plasma glucose was measured by glucose-oxidase method, serum C-peptide and serum cortisol by chemiluminescence’s based ELISA technique (Immulite, USA). Serum electrolytes were measured by Dry Chemistry method (DT-60, USA) Results: All the subjects were hemodynamically stable during surgery. Plasma glucose increased significantly in PT2. Serum cortisol was significantly higher in PT1 and PT2 than PT0. Conclusions: Total abdominal hysterectomy under general anesthesia in well controlled type 2 diabetic subjects is accompanied by a hyperglycemic response which results from rise of insulin antagonists like cortisol.
    [Show full text]
  • Hyperglycemia in Critically Ill Patients: Management and Prognosis
    Hyperglycemia in Critically Ill Patients: Management and Prognosis ORIGINAL PAPER doi: 10.5455/medarh.2015.69.157-160 © 2015 Amina Godinjak, Amer Iglica, Azra Burekovic, Selma Jusufovic, Med Arh. 2015 Jun; 69(3): 157-160 Anes Ajanovic, Ira Tancica, Adis Kukuljac Received: April 05th 2015 | Accepted: May 24th 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted Published online: 10/06/2015 Published print:06/2015 non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Hyperglycemia in Critically Ill Patients: Management and Prognosis Amina Godinjak1, Amer Iglica1, Azra Burekovic2, Selma Jusufovic1, Anes Ajanovic1, Ira Tancica1, Adis Kukuljac1 1Medical Intensive Care Unit, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina 2Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina Corresponding author: Amina Godinjak, MD, MSc. Medical intensive care unit, Clinical Center University of Sarajevo, Bolnička 25, 71000 Sarajevo, Bosnia and Herzegovina. e-mail: [email protected] ABSTRACT Introduction: Hyperglycemia is a common complication of critical illness. Patients in intensive care unit with stress hyperglycemia have significantly higher mortality (31%) compared to patients with previously confirmed diabetes (10%) or normoglycemia (11.3%). Stress hyperglycemia is associated with increased risk of critical illness polyneuropathy (CIP) and prolonged mechanical ventilation. Intensive monitoring and insulin therapy according to the protocol are an important part of the treatment of critically ill patients. Objective: To evaluate the incidence of stress hyperglycemia, complications and outcome in critically ill patients in our Medical intensive care unit.
    [Show full text]